Role of Sp Proteins in Regulation of Vascular Endothelial Growth Factor Expression and Proliferation of Pancreatic Cancer Cells

Sp proteins play an important role in angiogenesis and growth of cancer cells, and specificity protein 1 (Sp1) has been linked to vascular endothelial growth factor (VEGF) expression in pancreatic cancer cells. RNA interference was used to investigate the role of Sp family proteins on regulation of VEGF expression and proliferation of Panc-1 pancreatic cancer cells. Using a series of constructs containing VEGF promoter inserts, it was initially shown that Sp1 and Sp3 were required for transactivation, and this was primarily dependent on proximal GC-rich motifs. We also showed that Sp4 was expressed in Panc-1 cells, and RNA interference assays suggested that Sp4 cooperatively interacted with Sp1 and Sp3 to activate VEGF promoter constructs in these cells. However, the relative contributions of Sp proteins to VEGF expression were variable among different pancreatic cancer cell lines. Small inhibitory RNAs for Sp3, but not Sp1 or Sp4, inhibited phosphorylation of retinoblastoma protein, blocked G0/G1 → S-phase progression, and up-regulated p27 protein/promoter activity of Panc-1 cells; similar results were observed in other pancreatic cancer cells, suggesting that Sp3-dependent growth of pancreatic cancer cells is caused by inhibition of p27 expression.

[1]  J. Black,et al.  Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer , 2001, Journal of cellular physiology.

[2]  S. Philipsen,et al.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. , 1999, Nucleic acids research.

[3]  R. Schmid.  Genetic basis of pancreatic cancer. , 2002, Best practice & research. Clinical gastroenterology.

[4]  C. Caldas,et al.  K-ras mutation and pancreatic adenocarcinoma , 1995, International journal of pancreatology : official journal of the International Association of Pancreatology.

[5]  S. Safe,et al.  Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. , 2003, Endocrinology.

[6]  J. Knowelden,et al.  Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.

[7]  E. Wynder,et al.  Smoking and pancreatic cancer in men and women. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  Peter Wernet,et al.  Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells , 2002, Oncogene.

[9]  J S Wall,et al.  DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[11]  E A Eisen,et al.  Mortality studies of machining fluid exposure in the automobile industry. IV: A case-control study of lung cancer. , 1997, American journal of industrial medicine.

[12]  Y. Nio,et al.  Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  F. Mirer,et al.  A survey of mortality at two automotive engine manufacturing plants. , 1996, American journal of industrial medicine.

[14]  R. Hruban,et al.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. , 1994, Cancer research.

[15]  J. Cameron,et al.  Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. , 2000, The American journal of pathology.

[16]  B. Henderson,et al.  Pancreas cancer and smoking, beverage consumption, and past medical history. , 1986, Journal of the National Cancer Institute.

[17]  Donghui Li,et al.  Molecular epidemiology of pancreatic cancer , 2001, International journal of gastrointestinal cancer.

[18]  T. Kauppinen,et al.  Pancreatic Cancer and Occupational Exposures , 1995, Epidemiology.

[19]  N. Malats,et al.  Occurrence, trends and environment etiology of pancreatic cancer. , 1998, Scandinavian journal of work, environment & health.

[20]  K. Ohtsubo,et al.  Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  P. Hall,et al.  Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. , 1991, British Journal of Cancer.

[22]  T. Sakai,et al.  Molecular cloning and characterization of the human p27Kip1 gene promoter 1 , 1997, FEBS letters.

[23]  L. Lerner,et al.  Nrl and Sp nuclear proteins mediate transcription of rod-specific cGMP-phosphodiesterase beta-subunit gene: involvement of multiple response elements. , 2001, The Journal of biological chemistry.

[24]  S. Safe,et al.  Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor α and Sp3 Proteins* , 2000, The Journal of Biological Chemistry.

[25]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[26]  M. Husmann,et al.  Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation. , 2000, The Biochemical journal.

[27]  L. Lerner,et al.  The Rod cGMP-phosphodiesterase β-Subunit Promoter Is a Specific Target for Sp4 and Is Not Activated by Other Sp Proteins or CRX* , 2002, The Journal of Biological Chemistry.

[28]  Brad Saville,et al.  Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins , 2004, Oncogene.

[29]  S. C. Lin,et al.  Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. , 1997, Biochimica et biophysica acta.

[30]  Robert N. Hughes,et al.  Cancer: Principles and Practice of Oncology , 2005 .

[31]  W. Hung,et al.  Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen. , 2003, Biochemical pharmacology.

[32]  Scott E Kern,et al.  Focus on pancreas cancer. , 2002, Cancer cell.

[33]  R. Swerlick,et al.  Transforming growth factor‐α‐induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP‐2‐dependent DNA binding and transactivation , 1997, The EMBO journal.

[34]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[35]  R. Tjian,et al.  Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 , 1989, Cell.

[36]  T. Sakai,et al.  Sp1 and NF-Y Synergistically Mediate the Effect of Vitamin D3 in the p27Kip1 Gene Promoter That Lacks Vitamin D Response Elements* , 1999, The Journal of Biological Chemistry.

[37]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[38]  Mayumi Ono,et al.  Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells , 1996, The Journal of Biological Chemistry.

[39]  M. Abdelrahim,et al.  Small Inhibitory RNA Duplexes for Sp1 mRNA Block Basal and Estrogen-induced Gene Expression and Cell Cycle Progression in MCF-7 Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[40]  E. Holly,et al.  A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. , 2002, Journal of the National Cancer Institute.

[41]  J. Pouysségur,et al.  p42/p44 MAP Kinase Module Plays a Key Role in the Transcriptional Regulation of the Vascular Endothelial Growth Factor Gene in Fibroblasts* , 1998, The Journal of Biological Chemistry.

[42]  A. Miller,et al.  Cigarette smoking and cancer of the pancreas: Evidence from a population‐based case‐control study in Toronto, Canada , 1991, International journal of cancer.

[43]  E. Gold,et al.  Epidemiology of and risk factors for pancreatic cancer. , 1995, The Surgical clinics of North America.

[44]  J K McLaughlin,et al.  Pancreatitis and the risk of pancreatic cancer. , 1993, The New England journal of medicine.

[45]  D. Supp,et al.  Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility. , 1996, Developmental biology.

[46]  J. Abbruzzese,et al.  Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. , 2001, Cancer research.

[47]  G. Siemeister,et al.  Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression , 1997, Oncogene.

[48]  M. Pagano,et al.  Regulation of the Cdk inhibitor p27 and its deregulation in cancer , 2000, Journal of cellular physiology.

[49]  I. Weinstein,et al.  Multiple functions of p27Kip1 and its alterations in tumor cells: a review , 2000, Journal of cellular physiology.

[50]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. , 1993, The New England journal of medicine.

[51]  P Maisonneuve,et al.  Pancreatic Cancer: Development of a Unifying Etiologic Concept , 1999, Annals of the New York Academy of Sciences.

[52]  E. Eisen,et al.  Mortality studies of machining fluid exposure in the automobile industry. V: A case-control study of pancreatic cancer. , 1997, American journal of industrial medicine.

[53]  J. Cameron,et al.  The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[54]  S. Philipsen,et al.  Regulation of the activity of Sp1-related transcription factors , 2002, Molecular and Cellular Endocrinology.

[55]  Ahlgren Jd.  Epidemiology and risk factors in pancreatic cancer , 1996 .